Alvey Provides Model for Collaboration

Alvey Provides Model for Collaboration BY JOHN STANSELL LONDON - The Alvey program in advanced microelectronics leaves a legacy of cooperative research that promises to outlast the completion of its last individual project later this year. Begun in June 1983, Alvey proved to be a model for government- university-industry collaboration, for joint efforts among competing companies, and for cooperative research throughout Europe. It has also received high marks for luring top scientists back to

Written byJohn Stansell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

BY JOHN STANSELL

LONDON - The Alvey program in advanced microelectronics leaves a legacy of cooperative research that promises to outlast the completion of its last individual project later this year.

Begun in June 1983, Alvey proved to be a model for government- university-industry collaboration, for joint efforts among competing companies, and for cooperative research throughout Europe. It has also received high marks for luring top scientists back to Britain.

Britain failed to match similar efforts in microelectronics, artificial intelligence and software begun earlier in the decade by the United States and the Japanese because of battles between government departments and hostility between university-based and industrial researchers. The logjam, however, was broken by a 1982 report from a committee headed by John Alvey, head of R&D at British Telecom.

The new program was given a five-year budget of $630 million, almost half of which was to be provided by industry ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies